Prognostic value of PD-L1 expression on tumor cells combined with CD8+ TIL density in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy

BACKGROUND/AIM: mmune checkpoint inhibition (CPI) has an increasing impact in the multimodal treatment of locally advanced non-small cell lung cancer (LA-NSCLC). Increasing evidence suggests treatment outcome depending on tumor cell PD-L1 expression. The purpose of this retrospective study was to in...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Radiat Oncol
Main Authors: Gennen, Kathrin, Käsmann, Lukas, Taugner, Julian, Eze, Chukwuka, Karin, Monika, Roengvoraphoj, Olarn, Neumann, Jens, Tufman, Amanda, Orth, Michael, Reu, Simone, Belka, Claus, Manapov, Farkhad
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2020
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6941268/
https://ncbi.nlm.nih.gov/pubmed/31898519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-019-1453-3
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares